PAM
PDSB icon

Panagora Asset Management’s PDS Biotechnology PDSB Stock Holding History

Panagora Asset Management’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-3,932
Closed -$24K – 2592
2019
Q2 		$24K Sell
3,932
-447
-10% -$2.92K ﹤0.01% 2242
2019
Q1 		$32K Buy
4,379
+1,745
+66% +$14.6K ﹤0.01% 2157
2018
Q4 		$17K Buy
2,634
+905
+52% +$12K ﹤0.01% 2245
2018
Q3 		$28K Buy
1,729
+1,304
+307% +$23.4K ﹤0.01% 2156
2018
Q2 		$9K Buy
+425
New +$8.87K ﹤0.01% 2278
2017
Q3 		– Sell
-41
Closed -$8K – 2451
2017
Q2 		$8K Buy
+41
New +$8.08K ﹤0.01% 2484

Other funds holding PDSB

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
RC
RegentAtlantic Capital Morristown, New Jersey $3.34B AUM 14.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IGGA
Iron Gate Global Advisors Nsl, Utah $947M AUM 23.59% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Panagora Asset Management's PDSB Position: Q3 2019 in Review

Panagora Asset Management sold out of PDS Biotechnology (PDSB) in Q3 2019, closing a stake of 3,932 shares — an estimated $24K sold.

Panagora Asset Management first reported a position in PDSB in Q2 2017 and held it in 6 quarters. The position peaked at $32K in Q1 2019. 21 funds tracked by Wall St. Rank hold PDSB as of Q3 2019.

  • Panagora Asset Management reported no remaining PDS Biotechnology position as of Q3 2019 after selling out during the quarter.
  • Panagora Asset Management sold 3,932 PDS Biotechnology shares in Q3 2019, an estimated $24K.
  • Panagora Asset Management first reported a position in PDS Biotechnology in Q2 2017 and held it in 6 quarters.
  • Panagora Asset Management's PDS Biotechnology position peaked at $32K in Q1 2019.
  • 21 funds tracked by Wall St. Rank held PDS Biotechnology as of Q3 2019.

Based on Panagora Asset Management's 13F filing for Q3 2019, filed 12 Nov 2019.